Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Robins Chad M sold 600,000 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Aug 17 to Aug 18, 2026 · Filed Aug 19, 2026
From Aug 17 to Aug 18, 2026, Robins Chad M (Director, CEO and Chairman) sold 600,000 Adaptive Biotechnologies Corporation shares at an average US$24.80 for US$14.9M, leaving 2,180,518 shares. Filed Aug 19, 2026 (Form 4).
- Sold
- 600,000 shares
- Price
- US$24.80 average (US$24.48 to US$25.57)
- Value
- US$14.9M
- Holding after
- 2,180,518 shares
- Trading plan
- No
- Role
- Director, CEO and Chairman
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Option exercise | 321,324 | US$6.55 | 2,501,842 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 318,799 | US$25.08 | 2,183,043 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 2,525 | US$25.57 | 2,180,518 | Direct |
| Aug 18, 2026 | Common Stock | Option exercise | 278,676 | US$6.55 | 2,459,194 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 278,472 | US$24.48 | 2,180,722 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 204 | US$25.14 | 2,180,518 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Robins Chad M
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Robins Chad M · Apr 8, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026